Nordic Brain Tech: Difference between revisions
Created from NHT member research |
Created with researched data |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:Nordic Brain Tech}} | ||
|name=Nordic Brain Tech | {{Infobox company | ||
| | | name = Nordic Brain Tech AS | ||
| | | org_number = 923149430 | ||
| | | founded = 2019-06-19 | ||
|funding= | | employees = Not disclosed | ||
| | | address = Norway | ||
| industry = 72.100 – Biotechnology research | |||
| website = https://www.nordicbraintech.com | |||
| nht_category = Startup | |||
| description = Nordic Brain Tech develops Cenli, a digital therapeutic for migraine and headache. Cenli delivers science-backed biofeedback training at home — no clinic or appointments needed. Available in Norway. Part of the emerging digital therapeutics (DTx) category. | |||
| notes = No disclosed revenue or funding. Digital therapeutics for migraine is competitive (Biohaven, Nurax, etc.) but home-based biofeedback is differentiated. | |||
| related_companies = [[Nordlys AI]], [[Hemispherian]], [[Norway Health Tech]] | |||
| categories = Norway Health Tech, Startups, Digital Therapeutics, Neurology, Mental Health | |||
| sources = https://www.nordicbraintech.com; https://data.brreg.no/enhetsregisteret/api/enheter/923149430 | |||
}} | }} | ||
== | == About == | ||
Nordic Brain Tech AS is a Norwegian digital therapeutics company developing non-pharmacological interventions for migraine and headache disorders. Their flagship product, Cenli, provides biofeedback-based training that patients can use at home without requiring clinic visits. | |||
== | == Product == | ||
== | === Cenli === | ||
[[Category: | Cenli is a digital therapeutic for migraine and headache, available in Norway. Key features: | ||
[[Category: | * Science-backed biofeedback training | ||
* Home-based delivery — no clinic or appointments required | |||
* A few minutes per day training | |||
* Targets the nervous system through biofeedback | |||
== Market == | |||
Migraine affects approximately 1 billion people globally and is a leading cause of disability. Current treatments include acute medications (triptans, CGRP inhibitors) and preventive therapies. Non-pharmacological digital therapeutics address an unmet need for patients who cannot tolerate medications or prefer non-drug approaches. | |||
== References == | |||
<references/> | |||
[[Category:Norway Health Tech]] | |||
[[Category:Startups]] | |||
[[Category:Digital Therapeutics]] | |||
[[Category:Neurology]] | |||
[[Category:Mental Health]] | |||
Latest revision as of 20:31, 14 April 2026
About[edit]
Nordic Brain Tech AS is a Norwegian digital therapeutics company developing non-pharmacological interventions for migraine and headache disorders. Their flagship product, Cenli, provides biofeedback-based training that patients can use at home without requiring clinic visits.
Product[edit]
Cenli[edit]
Cenli is a digital therapeutic for migraine and headache, available in Norway. Key features:
- Science-backed biofeedback training
- Home-based delivery — no clinic or appointments required
- A few minutes per day training
- Targets the nervous system through biofeedback
Market[edit]
Migraine affects approximately 1 billion people globally and is a leading cause of disability. Current treatments include acute medications (triptans, CGRP inhibitors) and preventive therapies. Non-pharmacological digital therapeutics address an unmet need for patients who cannot tolerate medications or prefer non-drug approaches.